Drug Profile
Research programme: serotonin 4 receptor antagonists - Angelini
Alternative Names: AF3473Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Angelini Group
- Class
- Mechanism of Action Serotonin 4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Neuropathic pain
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Neuropathic-pain in Italy
- 25 Jul 2011 Preclinical development is ongoing in Italy
- 08 Apr 2008 Preclinical trials in Neuropathic pain in Italy (unspecified route)